Vulvovaginal Pyoderma Gangrenosum Secondary to Rituximab Therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Rituximab is being used increasingly for the treatment of B-cell malignancies and nonmalignant conditions. Pyoderma gangrenosum is a rare neutrophilic dermatosis, which can be either idiopathic or associated with underlying systemic inflammatory conditions. We present a series of 4 patients who presented with ulcerative pyoderma gangrenosum in the vulvovaginal area after treatment with rituximab.

Related Topics

    loading  Loading Related Articles